In last trading session, NRX Pharmaceuticals Inc (NASDAQ:NRXP) saw 0.32 million shares changing hands with its beta currently measuring 1.19. Company’s recent per share price level of $2.28 trading at -$0.17 or -6.94% at ring of the bell on the day assigns it a market valuation of $35.80M. That closing price of NRXP’s stock is at a discount of -221.49% from its 52-week high price of $7.33 and is indicating a premium of 51.75% from its 52-week low price of $1.10.

For NRX Pharmaceuticals Inc (NRXP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.29 in the current quarter.

NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information

Upright in the red during last session for losing -6.94%, in the last five days NRXP remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $2.28 price level, adding 25.73% to its value on the day. NRX Pharmaceuticals Inc’s shares saw a change of 3.64% in year-to-date performance and have moved -22.45% in past 5-day. NRX Pharmaceuticals Inc (NASDAQ:NRXP) showed a performance of -34.48% in past 30-days.

Wall Street analysts have assigned a consensus price target of 2 to the stock, which implies a fall of -14.0% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 2. It follows that stock’s current price would jump 12.28% in reaching the projected high whereas dropping to the targeted low would mean a gain of 12.28% for stock’s current value.

And 1 analysts are in estimates of company making revenue of 5M in the next quarter.

On the other hand, AdvisorShares Trust-AdvisorShares Psychedelics ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 318.5 shares of worth $0.73 million or 2.03% of the total outstanding shares. The later fund manager was in possession of 193.42 shares on Sep 30, 2024 , making its stake of worth around $0.44 million in the company or a holder of 1.23% of company’s stock.